502 PATIENT GLOBAL IMPRESSION OF CHANGE ASSOCIATED WITH TAPENTADOL PROLONGED RELEASE (PR) FOR THE MANAGEMENT OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY (DPN)